Explained herein are pharmaceutical packaging units which reduce oxidative degradation of morphine, hydromorphone, promethazine and various oxygen-sensitive drugs, these types of programs including a syringe using an oxygen permeable idea cap, a hermetically sealed oxygen barrier blister packaging with very low permeability to oxygen and comprises